![Jerry I. Treppel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jerry I. Treppel
Corporate Officer/Principal chez
Arclight Advisors LLC
Profil
Jerry I.
Treppel is currently a Managing Director at Arclight Advisors LLC.
He previously held positions such as Chairman at Elite Pharmaceuticals, Inc., Director at Akorn, Inc., Director at Able Laboratories, Inc., Director at Cangene Corp., Managing Director at Ledgemont Capital Group LLC, Managing Director at Ledgemont Private Equity, Analyst at Merrill Lynch & Co., Inc., Analyst at Teva Pharmaceutical Industries Ltd., Analyst at Sloate, Weisman, Murray & Co., Inc., Analyst at Banc of America Securities LLC, Analyst at Dillon, Read & Co., Inc., Principal at Kidder Peabody, Analyst at Furman Selz LLC, Managing Member at Wheaten Capital Management LLC, Principal at Montefiore Medical Center, General Partner & Fund Manager at Wheaten Healthcare Partners LP, and Principal at UBS Warburg, Inc. He received a graduate degree from Washington University in St. Louis, an undergraduate degree from Rutgers State University of New Jersey, and an MBA from New York University.
Postes actifs de Jerry I. Treppel
| Sociétés | Poste | Début |
|---|---|---|
Arclight Advisors LLC | Corporate Officer/Principal | - |
Anciens postes connus de Jerry I. Treppel
| Sociétés | Poste | Fin |
|---|---|---|
| ELITE PHARMACEUTICALS, INC. | Président | 11/01/2016 |
Ledgemont Private Equity
 Ledgemont Private Equity Investment ManagersFinance Ledgemont Private Equity focuses on a variety of sectors including technology, media and telecommunications, healthcare and pharmaceuticals and basic industrials, manufacturing and services. They generally invest $10 million to $100 million in companies with enterprise values from $50 million to $350 million. Ledgemont looks for strong management teams, companies undergoing recapitalizations or divestitures and underachieving companies due to operational or balance sheet issues | Private Equity Investor | 24/12/2013 |
Ledgemont Capital Group LLC
 Ledgemont Capital Group LLC Investment ManagersFinance Ledgemont Capital Group seeks to make select investments in businesses across diverse industry sectors, providing equity, debt and hybrid financing with an emphasis on interim and special situation opportunities. The firm sources, structures and supports investment opportunities. They create value in our portfolio companies through concentration on business development and often gain Board representation to assist in affecting agreed strategies. Ledgemont's investment approach is grounded in through due diligence, operational expertise and the fundamental analyses of underlying businesses. Their principal investments are generally made through special purpose vehicles (SPVs). | Gestionnaire de Portefeuille-Actions | 30/04/2013 |
Wheaten Capital Management LLC | Corporate Officer/Principal | - |
| AKORN, INC. | Directeur/Membre du Conseil | - |
Formation de Jerry I. Treppel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Able Laboratories, Inc.
 Able Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Elite Pharmaceuticals, Inc.
 Elite Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceutical products | Health Technology |
Sloate, Weisman, Murray & Co., Inc.
 Sloate, Weisman, Murray & Co., Inc. Investment ManagersFinance SWM is a multi-cap value manager. | Finance |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells biopharmaceutical drugs | Health Technology |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Dillon, Read & Co., Inc.
 Dillon, Read & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kidder Peabody
 Kidder Peabody Investment Banks/BrokersFinance Engaged in investment banking, brokerage and trading | Finance |
Furman Selz LLC
 Furman Selz LLC Investment Banks/BrokersFinance Provides institutional brokerage and investment banking services | Finance |
Wheaten Capital Management LLC | |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Montefiore Medical Center
 Montefiore Medical Center Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit hospital | Commercial Services |
Ledgemont Capital Group LLC
Ledgemont Capital Group LLC Investment ManagersFinance Ledgemont Capital Group seeks to make select investments in businesses across diverse industry sectors, providing equity, debt and hybrid financing with an emphasis on interim and special situation opportunities. The firm sources, structures and supports investment opportunities. They create value in our portfolio companies through concentration on business development and often gain Board representation to assist in affecting agreed strategies. Ledgemont's investment approach is grounded in through due diligence, operational expertise and the fundamental analyses of underlying businesses. Their principal investments are generally made through special purpose vehicles (SPVs). | Finance |
Wheaten Healthcare Partners LP | |
Ledgemont Private Equity
Ledgemont Private Equity Investment ManagersFinance Ledgemont Private Equity focuses on a variety of sectors including technology, media and telecommunications, healthcare and pharmaceuticals and basic industrials, manufacturing and services. They generally invest $10 million to $100 million in companies with enterprise values from $50 million to $350 million. Ledgemont looks for strong management teams, companies undergoing recapitalizations or divestitures and underachieving companies due to operational or balance sheet issues | Finance |
UBS Warburg, Inc. | |
Arclight Advisors LLC |
